Sorafenib case: the alleged legal presumption of validity of the patent admits evidence to the contrary in injunctive relief proceedings
[et_pb_section fb_built=”1″ _builder_version=”3.19.5″][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”2_5″ _builder_version=”3.0.47″ parallax=”off” parallax_method=”on”][et_pb_image src=”https://desarrollo.vidalquadrasramon.com/wp-content/uploads/2022/10/drugs-2.jpg” _builder_version=”3.19.5″][/et_pb_image][/et_pb_column][et_pb_column type=”3_5″ _builder_version=”3.0.47″ parallax=”off” parallax_method=”on”][et_pb_post_title comments=”off” featured_image=”off” _builder_version=”3.19.5″ title_level=”h4″ title_font=”||||||||”][/et_pb_post_title][et_pb_text _builder_version=”3.19.5″] In this brief note we refer to the Order of the Barcelona Provincial Court (15th Section) 59/2022 of 22 April, which confirmed the Order of the Barcelona Commercial Court No. 1 of ...








